Where is the live CopyMark page for USPTO serial 98601551?

The live record is at https://getcopymark.com/trademark/98601551. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns EMPOWER PHARMACY?

According to the public USPTO record for serial number 98601551, the listed owner(s) include: Empower Clinic Services, L.L.C..

What is USPTO serial number 98601551?

Serial number 98601551 is the USPTO application identifier for the mark EMPOWER PHARMACY. It is used to track examination, publication, and registration of this trademark.

What is the current status of EMPOWER PHARMACY?

EMPOWER PHARMACY (98601551) currently shows USPTO status code 654 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover EMPOWER PHARMACY?

The public record lists International Classes: 005, 010. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: EMPOWER PHARMACY Serial# 98601551 | status 654; last event RCSC | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EMPOWER PHARMACY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Empower Clinic Services, L.L.C.
Houston, TX, US
Other trademarks owned by Empower Clinic Services, L.L.C.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John A. Yates

John A. Yates Patterson + Sheridan, LLP24 Greenway PlazaSuite 1600Houston, TX 77046

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations for weight management, hormone replacement therapy, intravenous therapy, intravenous nutrition, injectable therapy, dietary nutrition, mental health, skin care, sexual dysfunction, fertility, men's health, women's health, and gender-affirming care; pharmaceutical preparations for the prevention, reduction, and treatment of cardiovascular, lymphatic, respiratory, pulmonary, neurological, renal, gastrointestinal, musculoskeletal, dermatological, allergic, inflammatory, autoimmune, gynecological, genetic, longevity, metabolic, and pain conditions; disinfecting wipes; and sanitizing wipes	ACTIVE	May 1, 2024
010	Medical syringes; disposable syringes; syringe barrels; luer lock syringe barrels; injection needles for medical use; vial adapters for syringes; trocars; and containers adapted for the disposal of medical instruments and syringes	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jul 26, 2026	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
May 4, 2026	DOCK	ASSIGNED TO EXAMINER	—
Jan 26, 2026	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Jul 25, 2025	GNS3	NOTIFICATION OF LETTER OF SUSPENSION E-MAILED	—
Jul 25, 2025	GNSL	LETTER OF SUSPENSION E-MAILED	—
Jul 25, 2025	CNSL	SUSPENSION LETTER WRITTEN	—
Jun 24, 2025	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Jun 24, 2025	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jun 24, 2025	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 7, 2025	XELG	APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED	—
Apr 7, 2025	XELR	APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED	—
Jan 6, 2025	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 6, 2025	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 6, 2025	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 6, 2025	DOCK	ASSIGNED TO EXAMINER	—
Jan 5, 2025	MDSC	NOTICE OF DESIGN SEARCH CODE E-MAILED	—
Jan 5, 2025	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Jun 14, 2024	NWAP	NEW APPLICATION ENTERED	—

EMPOWER PHARMACY